02696 復宏漢霖
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 股權變動
股權披露
配股集資
公司回購
日期 股東名稱 披露原因 買入／賣出涉及
的股份數目		 每股平均價 持有權益的
股份數目		 佔已發行
股本(%)
21/05/2026Morgan Stanley1311(L)9,000(L)17,415,856(L)
1,499,885(S)
0(P)		5.03
0.43
0.00
20/05/2026Morgan Stanley1013(L)+148,636(L)17,415,856(L)
1,499,885(S)
0(P)		5.03
0.43
0.00
19/05/2026Morgan Stanley1704(L)-387,221(L)17,267,220(L)
1,436,172(S)
0(P)		4.98
0.41
0.00
18/05/2026Morgan Stanley1311(L)3,900(L)18,584,615(L)
1,437,305(S)
0(P)		5.37
0.41
0.00
13/05/2026Morgan Stanley1013(L)+1,540,335(L)18,301,481(L)
1,437,051(S)
0(P)		5.28
0.41
0.00
11/02/2026CHING NGAI INDUSTRIES (CHINA) COMPANY LIMITED1201(L)-2,930,000(L)14,575,688(L)4.21
05/02/2026Golden Valley Value Select Master Fund1704(L)11,690,752(L)11,690,752(L)3.38
05/02/2026LVC Management Holdings Limited1704(L)11,690,752(L)11,690,752(L)3.38
05/02/2026LVC SG MANAGEMENT PTE. LTD.1704(L)11,690,752(L)11,690,752(L)3.38
05/02/2026Vistra Trust (Singapore) Pte. Limited1704(L)11,690,752(L)11,690,752(L)3.38
04/02/2026Morgan Stanley1704(L)-820,646(L)7,958,399(L)
322,431(S)
0(P)		2.29
0.09
0.00
04/02/2026XYXY Holdings Ltd.1704(L)12,149,900(L)3.51
04/02/2026郭廣昌1113(L)+120,000,000(L)152,331,100(L)44.02
04/02/2026Shanghai Fosun New Medicine Research Company Limited1113(L)-120,000,000(L)145,971,569(L)73.94
04/02/2026Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.1113(L)-120,000,000(L)192,399,700(L)97.46
04/02/2026Fosun Industrial Co., Limited1213(L)32,331,100(L)9.34
04/02/2026Fosun International Limited1113(L)-120,000,000(L)192,399,700(L)97.46
04/02/2026Fosun Holdings Limited1113(L)-120,000,000(L)192,399,700(L)97.46
04/02/2026Boyu Capital Investment Management Limited1704(L)12,149,900(L)3.51
04/02/2026Fosun International Limited1113(L)+120,000,000(L)152,331,100(L)44.02
04/02/2026Fosun International Holdings Ltd.1113(L)-120,000,000(L)192,399,700(L)97.46
04/02/2026郭廣昌1113(L)-120,000,000(L)192,399,700(L)97.46
04/02/2026朱俊1711(L)1,550,000(L)0.45
04/02/2026童小幪1704(L)12,149,900(L)3.51
04/02/2026Shanghai Fosun Pharmaceutical (Group) Co., Ltd.1113(L)+120,000,000(L)152,331,100(L)44.02
04/02/2026Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.1013(L)+120,000,000(L)120,000,000(L)34.67
04/02/2026Shanghai Fosun New Medicine Research Company Limited1013(L)+120,000,000(L)120,000,000(L)34.67
04/02/2026GIC Private Limited1704(L)11,890,400(L)3.44
04/02/2026Shanghai Fosun High Technology (Group) Co., Ltd.1113(L)-120,000,000(L)192,399,700(L)97.46
04/02/2026Shanghai Fosun Pharmaceutical (Group) Co., Ltd.1113(L)-120,000,000(L)192,399,700(L)97.46
04/02/2026Shanghai Fosun High Technology (Group) Co., Ltd.1113(L)+120,000,000(L)152,331,100(L)44.02
04/02/2026Fosun International Holdings Ltd.1113(L)+120,000,000(L)152,331,100(L)44.02
04/02/2026Boyu Capital Group Holdings Ltd.1704(L)12,149,900(L)3.51
04/02/2026Boyu Group, LLC1704(L)12,149,900(L)3.51
04/02/2026Taikang Insurance Group, Inc.1704(L)10,321,800(L)2.98
04/02/2026CHING NGAI INDUSTRIES (CHINA) COMPANY LIMITED1013(L)+17,505,688(L)17,505,688(L)5.06
04/02/2026Fosun Holdings Limited1113(L)+120,000,000(L)152,331,100(L)44.02
30/01/2026UBS Group AG1704(L)-2,168,815(L)6,406,642(L)
4,707,918(S)		3.92
2.88
29/01/2026Morgan Stanley1013(L)+883,745(L)8,686,133(L)
305,828(S)
0(P)		5.31
0.18
0.00
29/01/2026UBS Group AG1113(L)
1402(S)		+354,068(L)
+3,690,259(S)		8,302,498(L)
4,425,159(S)		5.08
2.71
  1   2    3    4    5    6    7  
備註： (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
  (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.